Company profile for Abide Therapeutics, Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Abide Therapeutics, we have the pipeline and the people to become the world leader in realizing the therapeutic value of serine hydrolases like the endocannabinoid modulator monoacylglycerol lipase, or MGLL. Our commitment is to develop novel medicines to transform the lives of patients with serious unmet medical needs. Serine hydrolases form a large enzyme family that plays key roles in human physiology and disease. Using ...
At Abide Therapeutics, we have the pipeline and the people to become the world leader in realizing the therapeutic value of serine hydrolases like the endocannabinoid modulator monoacylglycerol lipase, or MGLL. Our commitment is to develop novel medicines to transform the lives of patients with serious unmet medical needs. Serine hydrolases form a large enzyme family that plays key roles in human physiology and disease. Using our unique and proprietary serine hydrolase platform combined with our deep scientific and drug development expertise, we have advanced to the clinic a new class of drugs for neurological diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10835 Road to the Cure, Suite 250 San Diego, CA 92121
Telephone
Telephone
+1- (858) 427-2590
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/lundbeck-slashes-value-250m-abide-buyout-after-pain-setback

FIERCE BIOTECH
24 Oct 2024

http://www.pmlive.com/pharma_news/lundbecks_key_products_shine_in_q2_but_problems_remain_1297435

Nick Taylor PMLIVE
14 Aug 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty